Mitochondrial Multiorgan Disorder Syndrome Score Generated from Definite Mitochondrial Disorders

Overview

Journal Neuropsychiatr Dis Treat

Publisher Dove Medical Press

Specialty Psychiatry

Date 2017 Oct 25

PMID 29062232

Citations 9

Authors

Josef Finsterer

Sinda Zarrouk-Mahjoub

Affiliations

Soon will be listed here.

Abstract

Objectives: Mitochondrial disorders (MIDs) frequently present as mitochondrial multiorgan disorder syndrome (MIMODS) at onset or evolve into MIMODS during the course. This study aimed to find which organs and/or tissues are most frequently affected by MIMODS, which are the most frequent abnormalities within an affected organ, whether there are typical MIMODS patterns, and to generate an MIMODS score to assess the diagnostic probability for an MID.

Methods: This is a retrospective evaluation of clinical, biochemical, and genetic investigations of adult patients with definite MIDs. A total of 36 definite MID patients, 19 men and 17 women, aged 29-82 years were included in this study. The diagnosis was based on genetic testing (n=21), on biochemical investigations (n=17), or on both (n=2).

Results: The number of organs most frequently affected was 4 ranging from 1 to 9. MIMODS was diagnosed in 97% of patients. The organs most frequently affected were the muscle (97%), central nervous system (CNS; 72%), endocrine glands (69%), heart (58%), intestines (55%), and peripheral nerves (50%). The most frequent CNS abnormalities were leukoencephalopathy, prolonged visually evoked potentials, and atrophy. The most frequent endocrine abnormalities included thyroid dysfunction, short stature, and diabetes. The most frequent cardiac abnormalities included arrhythmias, systolic dysfunction, and hypertrophic cardiomyopathy. The most frequent MIMODS patterns were encephalomyopathy, encephalo-myo-endocrinopathy, and encepalo-myo-endocrino-cardiopathy. The mean ± 2SD MIMODS score was 35.97±27.6 (range =11-71). An MIMODS score >10 was regarded as indicative of an MID.

Conclusion: Adult MIDs manifest as MIMODS in the vast majority of the cases. The organs most frequently affected in MIMODS are muscles, CNS, endocrine glands, and heart. An MIMODS score >10 suggests an MID.

Citing Articles

The Novel Role of PGC1α in Bone Metabolism.

Buccoliero C, Dicarlo M, Pignataro P, Gaccione F, Colucci S, Colaianni G Int J Mol Sci. 2021; 22(9).

PMID: 33925111 PMC: 8124835. DOI: 10.3390/ijms22094670.

MELAS Missed for Years: Stroke-Like Lesions Are No Indication for Brain Biopsy.

Finsterer J Case Rep Neurol Med. 2020; 2019:9312451.

PMID: 31949962 PMC: 6948273. DOI: 10.1155/2019/9312451.

MELAS in a Walk-in Customer.

Finsterer J J Neurosci Rural Pract. 2019; 10(4):725-727.

PMID: 31831998 PMC: 6906091. DOI: 10.1055/s-0039-1700618.

Early identification of LHON carriers may improve outcome.

Finsterer J Rom J Ophthalmol. 2019; 63(1):102-103.

PMID: 31198904 PMC: 6531766.

Liability of sepsis is hardly determined by the COXI variant m.6459T>C.

Finsterer J J Cell Mol Med. 2018; 23(1):689-690.

PMID: 30334343 PMC: 6307762. DOI: 10.1111/jcmm.13957.

References

Doss S, Lohmann K, Seibler P, Arns B, Klopstock T, Zuhlke C . Recessive dystonia-ataxia syndrome in a Turkish family caused by a COX20 (FAM36A) mutation. J Neurol. 2013; 261(1):207-12. DOI: 10.1007/s00415-013-7177-7. View

Tay S, Nordli Jr D, Bonilla E, Null E, Monaco S, Hirano M . Aortic rupture in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Arch Neurol. 2006; 63(2):281-3. DOI: 10.1001/archneur.63.2.281. View

Burrage L, Tang S, Wang J, Donti T, Walkiewicz M, Luchak J . Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>A) in the mitochondrial encoded ATP6 gene. Mol Genet Metab. 2014; 113(3):207-12. PMC: 4253070. DOI: 10.1016/j.ymgme.2014.06.004. View

Brunetti-Pierri N, Pignatelli R, Fouladi N, Towbin J, Belmont J, Craigen W . Dilation of the aortic root in mitochondrial disease patients. Mol Genet Metab. 2011; 103(2):167-70. DOI: 10.1016/j.ymgme.2011.02.007. View

Lu H, Zhou Y, Hu J, Lei G, Zhu M, Li K . Mitochondrial DNA deletion mutations in articular chondrocytes of cartilage affected by osteoarthritis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006; 31(5):640-4. View

Lovan A, Ul Haq I, Balakrishnan N . Diagnostic challenges in movement disorders: Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia (SANDO) syndrome. BMJ Case Rep. 2013; 2013. PMC: 3761684. DOI: 10.1136/bcr-2013-010343. View

Vissing C, Duno M, Olesen J, Rafiq J, Risom L, Christensen E . Recurrent myoglobinuria and deranged acylcarnitines due to a mutation in the mtDNA MT-CO2 gene. Neurology. 2013; 80(20):1908-10. DOI: 10.1212/WNL.0b013e3182929fb2. View

La Morgia C, Caporali L, Gandini F, Olivieri A, Toni F, Nassetti S . Association of the mtDNA m.4171C>A/MT-ND1 mutation with both optic neuropathy and bilateral brainstem lesions. BMC Neurol. 2014; 14:116. PMC: 4047257. DOI: 10.1186/1471-2377-14-116. View

Varanasi S, Francis R, Berger C, Papiha S, Datta H . Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int. 1999; 10(2):143-9. DOI: 10.1007/s001980050209. View

10.

Barrientos A, Casademont J, Grau J, Cardellach F, Montoya J, Estivill X . [Progressive external ophthalmoplegia and the Kearns-Sayre syndrome: a clinical and molecular study of 6 cases]. Med Clin (Barc). 1995; 105(5):180-4. View

11.

Ryther R, Cho-Park Y, Lee J . Carotid dissection in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. J Neurol. 2010; 258(5):912-4. DOI: 10.1007/s00415-010-5818-7. View

12.

Danpure C, Lumb M, Birdsey G, Zhang X . Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease. Biochim Biophys Acta. 2003; 1647(1-2):70-5. DOI: 10.1016/s1570-9639(03)00055-4. View

13.

Mulliez E, BLANCKAERT M, Blanckaert J . Acute manifestation of LHON and coincidental finding of a pituitary adenoma: a case report. Bull Soc Belge Ophtalmol. 2000; (277):35-42. View

14.

Pfeffer G, Sirrs S, Wade N, Mezei M . Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci. 2010; 38(1):119-23. DOI: 10.1017/s031716710001115x. View

15.

Blanco-Grau A, Bonaventura-Ibars I, Coll-Canti J, Melia M, Martinez R, Martinez-Gallo M . Identification and biochemical characterization of the novel mutation m.8839G>C in the mitochondrial ATP6 gene associated with NARP syndrome. Genes Brain Behav. 2013; 12(8):812-20. DOI: 10.1111/gbb.12089. View

16.

Gurrieri C, Kivela J, Bojanic K, Gavrilova R, Flick R, Sprung J . Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series. Can J Anaesth. 2011; 58(8):751-63. DOI: 10.1007/s12630-011-9528-0. View

17.

Rubegni A, Cardaioli E, Chini E, Da Pozzo P, Battisti C, Malandrini A . A case of 3243A>G mutation in mtDNA presenting as apparently idiopathic hyperCKemia. J Neurol Sci. 2014; 338(1-2):232-4. DOI: 10.1016/j.jns.2014.01.010. View

18.

Uusimaa J, Evans J, Smith C, Butterworth A, Craig K, Ashley N . Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene. Eur J Hum Genet. 2013; 22(2):184-91. PMC: 3895632. DOI: 10.1038/ejhg.2013.112. View

19.

Chang M, Hung S, Chen W, Chen T, Lee C, Lee H . Accumulation of mitochondrial DNA with 4977-bp deletion in knee cartilage--an association with idiopathic osteoarthritis. Osteoarthritis Cartilage. 2005; 13(11):1004-11. DOI: 10.1016/j.joca.2005.06.011. View

20.

Jimenez Caballero P, Candela M, Alvarez C, Tejerina A . Chronic progressive external ophthalmoplegia: a report of 6 cases and a review of the literature. Neurologist. 2007; 13(1):33-6. DOI: 10.1097/01.nrl.0000252953.49721.f5. View